RSS

Exscientia

Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets. more

5 Jul 2017 12:13 News